GPN vs RIGL · P/E 24, rev $6.29B vs P/E 9.1, rev $137.5M
Global Payments Inc (GPN) versus Rigel Pharmaceuticals Inc (RIGL) — a side-by-side from cached financials, not a winner call.
Global Payments Inc (GPN) is a specialty business services company listed on US.
Rigel Pharmaceuticals Inc (RIGL) is a biotechnology company listed on US.
Latest reported GPN revenue for 2026-06-30 was $6.29B. Net income was -$1.79B. GPN currently screens at market cap $18.14B and trailing P/E 24.4.
Latest reported RIGL revenue for 2026-06-30 was $137.5M. Net income was $25.9M. RIGL currently screens at market cap $338.3M and trailing P/E 9.1.
GPN currently screens at market cap $18.14B and trailing P/E 24.4. RIGL currently screens at market cap $338.3M and trailing P/E 9.1.
Not investment advice. Open the GPN and RIGL stock pages for the full models.
Not investment advice.